Patents by Inventor Christopher John ROTHWELL

Christopher John ROTHWELL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Molecules and methods for modulating TMEM16A activities
    Patent number: 9045546
    Abstract: The present invention provides molecules that bind to TMEM16A (“TMEM16A binding molecules”), particularly human or humanized antibodies and antibody drug conjugates that bind to human TMEM16A and modulate its functions. Epitopes of TMEM16A and molecules that bind these epitopes are also provided herein.
    Type: Grant
    Filed: November 30, 2012
    Date of Patent: June 2, 2015
    Assignee: NOVARTIS AG
    Inventors: Larry Alexander Gaither, Christopher John Rothwell
  • Molecules and methods for modulating TMEM16A activities
    Patent number: 8748587
    Abstract: The present invention provides molecules that bind to TMEM16A (“TMEM16A binding molecules”), particularly human or humanized antibodies and antibody drug conjugates that bind to human TMEM16A and modulate its functions. Epitopes of TMEM16A and molecules that bind these epitopes are also provided herein.
    Type: Grant
    Filed: May 31, 2012
    Date of Patent: June 10, 2014
    Assignee: Novartis AG
    Inventors: Larry Alexander Gaither, Christopher John Rothwell
  • Molecules And Methods For Modulating TMEM16A Activities
    Publication number: 20130323252
    Abstract: The present invention provides molecules that bind to TMEM16A (“TMEM16A binding molecules”), particularly human or humanized antibodies and antibody drug conjugates that bind to human TMEM16A and modulate its functions. Epitopes of TMEM16A and molecules that bind these epitopes are also provided herein.
    Type: Application
    Filed: November 30, 2012
    Publication date: December 5, 2013
    Applicant: Novartis AG
    Inventors: Larry Alexander Gaither, Christopher John Rothwell
  • MOLECULES AND METHODS FOR MODULATING TMEM16A ACTIVITIES
    Publication number: 20120308582
    Abstract: The present invention provides molecules that bind to TMEM16A (“TMEM16A binding molecules”), particularly human or humanized antibodies and antibody drug conjugates that bind to human TMEM16A and modulate its functions. Epitopes of TMEM16A and molecules that bind these epitopes are also provided herein.
    Type: Application
    Filed: May 31, 2012
    Publication date: December 6, 2012
    Applicant: NOVARTIS AG
    Inventors: Larry Alexander GAITHER, Christopher John ROTHWELL